BIORESTORATIVE THERAPIES, INC. Interest Expense
BIORESTORATIVE THERAPIES, INC. (BRTX) reported Interest Expense of $28.84 thousand for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2022-11-14
- BIORESTORATIVE THERAPIES, INC. interest expense for the quarter ending 2022-09-30 was $28.84K, a 94.18% decline year-over-year.
- BIORESTORATIVE THERAPIES, INC. interest expense for the quarter ending 2021-09-30 was $495.55K.
- BIORESTORATIVE THERAPIES, INC. interest expense for the quarter ending 2016-03-31 was $42.84K, a 33.73% decline year-over-year.
- BIORESTORATIVE THERAPIES, INC. interest expense for the quarter ending 2015-12-31 was $58.20K, a 10.43% decline year-over-year.
- BIORESTORATIVE THERAPIES, INC. interest expense for fiscal 2015 was $263.58K, a 7.60% decline from fiscal 2014.
- BIORESTORATIVE THERAPIES, INC. interest expense for fiscal 2014 was $285.27K, a 23.16% decline from fiscal 2013.
- BIORESTORATIVE THERAPIES, INC. interest expense for fiscal 2013 was $371.28K, a 37.26% decline from fiscal 2012.
- BIORESTORATIVE THERAPIES, INC. interest expense for fiscal 2012 was $591.81K, a 127.61% increase from fiscal 2011.
| Period end | Interest Expense 3 month | Interest Expense 3 month as first filed | Interest Expense 6 month | Interest Expense 6 month as first filed | Interest Expense 9 month | Interest Expense 9 month as first filed | Interest Expense 12 month | Interest Expense 30 month | Interest Expense 33 month | Interest Expense 36 month | Interest Expense 39 month | Interest Expense 42 month | Interest Expense 45 month | Interest Expense 48 month | Interest Expense 51 month | Interest Expense 54 month | Interest Expense 57 month | Interest Expense 60 month | Interest Expense 63 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-09-30 | $28.84K 10-Q · filed 2022-11-14 | $104.47K 10-Q · filed 2022-11-14 | |||||||||||||||||
| 2021-09-30 | $495.55K 10-Q · filed 2022-11-14 | $1.60M 10-Q · filed 2022-11-14 | |||||||||||||||||
| 2016-03-31 | $42.84K 10-Q · filed 2016-05-13 | $101.04K derived: sum of 2 quarters · filed 2016-05-13 | $181.69K derived: sum of 3 quarters · filed 2016-05-13 | $241.78K derived: sum of 4 quarters · filed 2016-05-13 | |||||||||||||||
| 2015-12-31 | $58.20K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $138.85K derived: sum of 2 quarters · filed 2016-03-30 | $198.94K derived: sum of 3 quarters · filed 2016-03-30 | $263.58K 10-K · filed 2016-03-30 | |||||||||||||||
| 2015-09-30 | $80.65K 10-Q · filed 2015-11-23 | $140.74K derived: sum of 2 quarters · filed 2015-11-23 | $205.38K 10-Q · filed 2015-11-23 | $270.36K derived: sum of 4 quarters · filed 2016-05-13 | |||||||||||||||
| 2015-06-30 | $60.10K 10-Q · filed 2015-08-14 | $124.74K 10-Q · filed 2015-08-14 | $189.71K derived: sum of 3 quarters · filed 2016-05-13 | $264.49K derived: sum of 4 quarters · filed 2016-05-13 | |||||||||||||||
| 2015-03-31 | $64.64K 10-Q · filed 2016-05-13 | $129.61K derived: sum of 2 quarters · filed 2016-05-13 | $204.39K derived: sum of 3 quarters · filed 2016-05-13 | $276.78K derived: sum of 4 quarters · filed 2016-05-13 | |||||||||||||||
| 2014-12-31 | $64.97K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $139.75K derived: sum of 2 quarters · filed 2016-03-30 | $212.14K derived: sum of 3 quarters · filed 2016-03-30 | $285.27K 10-K · filed 2016-03-30 | |||||||||||||||
| 2014-09-30 | $74.78K 10-Q · filed 2015-11-23 | $147.17K derived: sum of 2 quarters · filed 2015-11-23 | $220.30K 10-Q · filed 2015-11-23 | $305.64K derived: sum of 4 quarters · filed 2015-11-23 | |||||||||||||||
| 2014-06-30 | $72.39K 10-Q · filed 2015-08-14 | $145.52K 10-Q · filed 2015-08-14 | $230.86K derived: sum of 3 quarters · filed 2015-08-14 | $286.90K derived: sum of 4 quarters · filed 2015-08-14 | |||||||||||||||
| 2014-03-31 | $73.13K 10-Q · filed 2015-05-15 | $158.47K derived: sum of 2 quarters · filed 2015-05-15 | $214.51K derived: sum of 3 quarters · filed 2015-05-15 | $246.54K derived: sum of 4 quarters · filed 2015-05-15 | $1.32M 10-Q · filed 2014-05-14 | ||||||||||||||
| 2013-12-31 | $85.34K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-31 | $141.38K derived: sum of 2 quarters · filed 2015-03-31 | $173.41K derived: sum of 3 quarters · filed 2015-03-31 | $371.28K 10-K · filed 2015-03-31 | $1.25M 10-K · filed 2014-04-11 | ||||||||||||||
| 2013-09-30 | $56.04K 10-Q · filed 2014-11-13 | $88.07K derived: sum of 2 quarters · filed 2014-11-13 | $285.94K 10-Q · filed 2014-11-13 | $414.18K derived: sum of 4 quarters · filed 2014-11-13 | $1.17M 10-Q · filed 2013-11-19 | ||||||||||||||
| 2013-06-30 | $32.03K 10-Q · filed 2014-08-14 | $229.90K 10-Q · filed 2014-08-14 | $358.15K derived: sum of 3 quarters · filed 2014-08-14 | $530.56K derived: sum of 4 quarters · filed 2014-08-14 | $1.11M 10-Q · filed 2013-08-19 | ||||||||||||||
| 2013-03-31 | $197.87K 10-Q · filed 2014-05-14 | $326.11K derived: sum of 2 quarters · filed 2014-05-14 | $498.52K derived: sum of 3 quarters · filed 2014-05-14 | $662.58K derived: sum of 4 quarters · filed 2014-05-14 | $1.08M 10-Q · filed 2013-05-15 | ||||||||||||||
| 2012-12-31 | $128.24K derived: 10-K 12 month − 10-Q 9 month · filed 2014-04-11 | $300.65K derived: sum of 2 quarters · filed 2014-04-11 | $464.72K derived: sum of 3 quarters · filed 2014-04-11 | $591.81K 10-K · filed 2014-04-11 | $880.31K 10-K · filed 2013-04-02 | ||||||||||||||
| 2012-09-30 | $172.41K 10-Q · filed 2013-11-19 | $336.47K derived: sum of 2 quarters · filed 2013-11-19 | $463.57K 10-Q · filed 2013-11-19 | $565.37K derived: sum of 4 quarters · filed 2013-11-19 | $752.07K 10-Q · filed 2012-11-05 | ||||||||||||||
| 2012-06-30 | $164.06K 10-Q · filed 2013-08-19 | $291.16K 10-Q · filed 2013-08-19 | $392.96K derived: sum of 3 quarters · filed 2013-08-19 | $467.91K derived: sum of 4 quarters · filed 2013-08-19 | $579.66K 10-Q · filed 2012-08-14 | ||||||||||||||
| 2012-03-31 | $127.10K 10-Q · filed 2013-05-15 | $228.90K derived: sum of 2 quarters · filed 2013-05-15 | $303.85K derived: sum of 3 quarters · filed 2013-05-15 | $362.70K derived: sum of 4 quarters · filed 2013-05-15 | $415.60K 10-Q/A · filed 2012-06-01 | ||||||||||||||
| 2011-12-31 | $101.80K derived: 10-K 12 month − 10-Q 9 month · filed 2013-04-02 | $176.76K derived: sum of 2 quarters · filed 2013-04-02 | $235.60K derived: sum of 3 quarters · filed 2013-04-02 | $260.01K 10-K · filed 2013-04-02 | $288.50K 10-K · filed 2012-04-16 | ||||||||||||||
| 2011-09-30 | $74.95K 10-Q · filed 2012-11-05 | $160.38K 10-Q · filed 2011-11-21 | $133.80K derived: sum of 2 quarters · filed 2012-11-05 | $158.21K 10-Q · filed 2012-11-05 | $422.48K 10-Q · filed 2011-11-21 | $12.43K derived: sum of 4 quarters · filed 2012-11-05 | $661.70K 10-Q · filed 2011-11-21 | ||||||||||||
| 2011-06-30 | $58.85K 10-Q · filed 2012-08-14 | $166.61K 10-Q/A · filed 2011-09-14 | $83.25K 10-Q · filed 2012-08-14 | $262.10K 10-Q/A · filed 2011-09-14 | -$62.52K derived: sum of 3 quarters · filed 2012-08-14 | -$43.71K derived: sum of 4 quarters · filed 2012-08-14 | $501.31K 10-Q/A · filed 2011-09-14 | ||||||||||||
| 2011-03-31 | $24.40K 10-Q/A · filed 2012-06-01 | -$121.37K derived: sum of 2 quarters · filed 2012-06-01 | -$102.56K derived: sum of 3 quarters · filed 2012-06-01 | -$72.81K derived: sum of 4 quarters · filed 2012-06-01 | |||||||||||||||
| 2010-12-31 | -$145.78K derived: 10-K 12 month − 10-Q 9 month · filed 2012-04-16 | -$126.97K derived: sum of 2 quarters · filed 2012-04-16 | -$97.21K derived: sum of 3 quarters · filed 2012-04-16 | $24.16K 10-K · filed 2012-04-16 | |||||||||||||||
| 2010-09-30 | $18.81K 10-Q · filed 2011-11-21 | $48.57K derived: sum of 2 quarters · filed 2011-11-21 | $169.93K 10-Q · filed 2011-11-21 | ||||||||||||||||
| 2010-06-30 | $29.76K 10-Q/A · filed 2011-09-14 | $151.12K 10-Q/A · filed 2011-09-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |